Cargando…

Inhibition of SARS-CoV 3CL protease by flavonoids

There were severe panics caused by Severe Acute Respiratory Syndrome (SARS) and Middle-East Respiratory Syndrome-Coronavirus. Therefore, researches targeting these viruses have been required. Coronaviruses (CoVs) have been rising targets of some flavonoids. The antiviral activity of some flavonoids...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Seri, Kim, Suwon, Shin, Dong Hae, Kim, Mi-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882434/ https://www.ncbi.nlm.nih.gov/pubmed/31724441 http://dx.doi.org/10.1080/14756366.2019.1690480

Ejemplares similares

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2020)

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
por: Jo, Seri, et al.
Publicado: (2021)

A Study of Drug Repurposing to Identify SARS-CoV-2 Main Protease (3CLpro) Inhibitors
por: Jo, Seri, et al.
Publicado: (2022)

Inhibition of African swine fever virus protease by myricetin and myricitrin
por: Jo, Seri, et al.
Publicado: (2020)

GTP Preference of d-Glycero-α-d-manno-Heptose-1-Phosphate Guanylyltransferase from Yersinia pseudotuberculosis
por: Kim, Suwon, et al.
Publicado: (2019)

A study of Rose Bengal against a 2-keto-3-deoxy-d-manno-octulosonate cytidylyltransferase as an antibiotic candidate
por: Kim, Suwon, et al.
Publicado: (2020)

A study of inhibitors of d-glycero-β-d-manno-heptose-1-phosphate adenylyltransferase from Burkholderia pseudomallei as a potential antibiotic target
por: Kim, Suwon, et al.
Publicado: (2021)

Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib
por: Niesor, Eric J, et al.
Publicado: (2021)

Dimerization Tendency of 3CLpros of Human Coronaviruses Based on the X-ray Crystal Structure of the Catalytic Domain of SARS-CoV-2 3CLpro
por: Jo, Seri, et al.
Publicado: (2022)

Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication
por: Lin, Lin, et al.
Publicado: (2023)

Rational design of flavonoid based potential inhibitors targeting SARS-CoV 3CL protease for the treatment of COVID-19
por: Bhati, Shipra, et al.
Publicado: (2021)

Mechanism of the Maturation Process of SARS-CoV 3CL Protease
por: Hsu, Min-Feng, et al.
Publicado: (2005)

Eupatin, a Flavonoid, Inhibits Coronavirus 3CL Protease and Replication
por: Park, Yea-In, et al.
Publicado: (2023)

Allosteric inhibition of SARS-CoV-2 3CL protease by colloidal bismuth subcitrate
por: Tao, Xuan, et al.
Publicado: (2021)

Inhibition of the SARS-CoV-2 3CL(pro) main protease by plant polyphenols
por: Bahun, Miha, et al.
Publicado: (2022)

In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease
por: Zeyaullah, Md., et al.
Publicado: (2023)

Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa
por: Cho, Jung Keun, et al.
Publicado: (2013)

Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease
por: Qiao, Zhen, et al.
Publicado: (2020)

Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses
por: Brier, Lucile, et al.
Publicado: (2023)

Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble
por: Kidera, Akinori, et al.
Publicado: (2021)

Testing Affordable Strategies for the Computational Study of Reactivity in Cysteine Proteases: The Case of SARS-CoV-2 3CL Protease Inhibition
por: Ramos-Guzmán, Carlos A., et al.
Publicado: (2022)

Tea Polyphenols EGCG and Theaflavin Inhibit the Activity of SARS-CoV-2 3CL-Protease In Vitro
por: Jang, Minsu, et al.
Publicado: (2020)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2020)

Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor
por: Konno, Hiroyuki, et al.
Publicado: (2017)

Evaluation of metal‐conjugated compounds as inhibitors of 3CL protease of SARS‐CoV
por: Hsu, John T.-A., et al.
Publicado: (2004)

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
por: Chan, Lee-Chin, et al.
Publicado: (2023)

Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
por: Liu, Yu-Chih, et al.
Publicado: (2005)

Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease
por: Ramajayam, R., et al.
Publicado: (2010)

Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
por: Shao, Yi-Ming, et al.
Publicado: (2008)

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
por: Wang, Qian, et al.
Publicado: (2023)

In silico prediction of the inhibition of new molecules on SARS-CoV-2 3CL protease by using QSAR: PSOSVR approach
por: Madani, Achouak, et al.
Publicado: (2023)

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition
por: Ryu, Young Bae, et al.
Publicado: (2010)

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance
por: Ip, Jonathan Daniel, et al.
Publicado: (2023)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
por: Pavan, Matteo, et al.
Publicado: (2022)

Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
por: Iketani, Sho, et al.
Publicado: (2021)

An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease
por: Zhai, Tianhua, et al.
Publicado: (2021)

Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites
por: Iketani, Sho, et al.
Publicado: (2022)

Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro)
por: Ma, Ling, et al.
Publicado: (2022)

Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally
por: Kawashima, Sho, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1m70g2gdb9akpbmdqhh9pt598c